HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean-Jacques Garaud Selected Research

Infections

10/2002Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean-Jacques Garaud Research Topics

Disease

3Septic Shock (Toxic Shock Syndrome)
10/2023 - 10/2018
1COVID-19
06/2023
1Pneumonia (Pneumonitis)
06/2023
1Rheumatoid Arthritis
08/2005
1Osteoarthritis
08/2005
1Stroke (Strokes)
08/2005
1Infections
10/2002
1Chronic Hepatitis C
10/2002

Drug/Important Bio-Agent (IBA)

4nangibotideIBA
10/2023 - 10/2018
2Triggering Receptor Expressed on Myeloid Cells-1IBA
10/2023 - 10/2018
1Biomarkers (Surrogate Marker)IBA
10/2023
1Peptides (Polypeptides)IBA
10/2018
1rofecoxib (Vioxx)FDA Link
08/2005
1lumiracoxib (prexige)IBA
08/2005
1Celecoxib (Celebrex)FDA Link
08/2005
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
08/2005
1Diclofenac (SR 38)FDA LinkGeneric
08/2005
1Ibuprofen (Motrin)FDA LinkGeneric
08/2005
1Naproxen (Naprosyn)FDA LinkGeneric
08/2005
1InterferonsIBA
10/2002
1Antiviral Agents (Antivirals)IBA
10/2002
1Ribavirin (Virazole)FDA LinkGeneric
10/2002

Therapy/Procedure

2Therapeutics
10/2018 - 10/2002
1Precision Medicine
06/2023